Triple Jump

Company Overview

Snapshot

Founded in April 2015 by Ofer Yodfat and Guy Shinar, Triple Jump operates with 11–50 employees. The company has raised $20 million across one funding round from 4 investors, with Medtronic identified as a lead investor. In October 2021, the company was reportedly in talks for an acquisition by Medtronic for $300 million.

Business overview

Triple Jump is developing an innovative small insulin pump patch for patients with diabetes. The system is designed to be placed on the patient's body, featuring mobile connectivity capabilities, and is intended for integration into a future artificial pancreas system. The company's product comprises a compact, fully portable, battery-operated miniature insulin pump and a hand-held controller, along with supporting accessories and sterile single-use disposables. Triple Jump operates within the Health Tech & Life Sciences sector, specifically focusing on drug delivery and medical devices for patients with diabetes.

Strategic signal

In October 2021, Triple Jump was reported to be in acquisition talks with Medtronic for $300 million. This indicates significant strategic validation for Triple Jump's insulin pump technology and its potential to be integrated into larger medical device portfolios, signaling strong commercial interest and a potential exit pathway for investors.

Company Intelligence Q&A

What is Triple Jump's core product?

Triple Jump is developing an innovative small insulin pump patch for patients with diabetes. This device is designed for body placement, includes mobile connectivity, and is intended for use within a future artificial pancreas system.

When was Triple Jump founded and by whom?

Triple Jump was founded in April 2015 by Ofer Yodfat and Guy Shinar.

What was a significant funding event for Triple Jump?

In September 2020, Triple Jump secured a funding round with Medtronic as a lead investor. The company has raised a total of $20 million across one funding round.

What was a notable acquisition discussion involving Triple Jump?

In October 2021, Medtronic was reportedly in talks to acquire Triple Jump for $300 million, highlighting significant interest in the company's insulin pump technology.

What is the employee size of Triple Jump?

Triple Jump currently has 11–50 employees.